Clinical Trials

Phase 2 Active not recruiting

Neuroblastoma

NCT04743661 2026-02-05

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

62 enrolled

Phase 2 Active not recruiting

Ependymoma, Medulloblastoma

NCT02595424 2025-12-29

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

67 enrolled

Endocrine

Somatostatinoma, Carcinoma, Neuroendocrine

NCT05040360 2025-12-15

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Phase 2 Recruiting

141 enrolled

Adenoma, Islet Cell

NCT00114140 2024-07-08

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

136 enrolled 9 charts

Astrocytoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00080938 2023-06-29

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

26 enrolled 8 charts

CNSThoracic

Adenocarcinoma of Lung, Brain Neoplasms, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00100802 2023-02-15

Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

118 enrolled 8 charts

Astrocytoma, Glioblastoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

NCT02727387 2022-09-19

EW-2

155 enrolled

Sarcoma

Sarcoma, Ewing

NCT02358356 2022-07-05

CONTROL NETS

75 enrolled

Neuroectodermal Tumors, Primitive

NCT04796454 2022-06-01

PAMICC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

NCT01164189 2019-02-28

TAVAREC

155 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT01019434 2018-07-09

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

111 enrolled

Glioblastoma, Central Nervous System Neoplasms

NCT00086879 2017-07-27

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

110 enrolled

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00311584 2014-09-30

Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma

59 enrolled 10 charts

Neuroblastoma

NCT00099125 2014-01-24

Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

170 enrolled

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00005597 2013-01-03

S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

25 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00003731 2012-09-24

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

39 enrolled

Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00104988 2012-08-22

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

64 enrolled

Dermatologic

Melanoma

NCT00003062 2012-07-02

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

70 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003304 2012-03-06

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

29 enrolled